Strand AI
Multimodal foundation models that impute missing patient biology data for clinical trial selection.
About
Strand AI predicts missing patient biological data modalities, such as proteomics and transcriptomics, from existing data like H&E slides and genotypes. This enables life sciences and drug discovery companies to rescue incomplete patient cohorts, find hidden biomarkers, and select the right patients for clinical trials. Their platform helps overcome the challenges of expensive and invasive data acquisition by filling in the gaps from data already collected. Teams look it up for Foundation Model, Multimodal AI, AI Drug Discovery.
Frequently asked
What does Strand AI do?
Strand AI is a Foundation Model company that offers Platform. Teams look it up for Multimodal AI, AI Drug Discovery, Clinical Trials. It is based in San Francisco, United States and was founded in 2025. Public records show about 2 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Strand AI headquartered?
Strand AI is headquartered in San Francisco, United States.
When was Strand AI founded?
Strand AI was founded in 2025.
What industry does Strand AI operate in?
Strand AI operates in Foundation Model, Multimodal AI, AI Drug Discovery, Clinical Trials, Genomics.
How many employees does Strand AI have?
Strand AI has approximately 2 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.